Home/Filings/4/0001062993-23-016265
4//SEC Filing

Kummeth Charles R. 4

Accession 0001062993-23-016265

CIK 0000842023other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 4:13 PM ET

Size

22.9 KB

Accession

0001062993-23-016265

Insider Transaction Report

Form 4
Period: 2023-08-09
Kummeth Charles R.
DirectorChief Executive Officer
Transactions
  • Gift

    Common Stock

    2023-08-099,0081,269,312 total
Holdings
  • Restricted Stock Units

    Common Stock (52,900 underlying)
    52,900
  • Restricted Stock Units

    Common Stock (32,064 underlying)
    32,064
  • Stock Options (Right to Buy)

    Exercise: $120.45Exp: 2028-08-06Common Stock (83,504 underlying)
    83,504
  • Common Stock

    (indirect: By Step-Son)
    400
  • Common Stock

    (indirect: By Step-Daughter)
    400
  • Stock Options (Right to Buy)

    Exercise: $31.26Exp: 2024-08-09Common Stock (779,084 underlying)
    779,084
  • Stock Options (Right to Buy)

    Exercise: $44.33Exp: 2025-08-08Common Stock (361,336 underlying)
    361,336
  • Stock Options (Right to Buy)

    Exercise: $44.33Exp: 2025-08-08Common Stock (240,888 underlying)
    240,888
  • Stock Options (Right to Buy)

    Exercise: $47.60Exp: 2026-08-07Common Stock (342,900 underlying)
    342,900
  • Stock Options (Right to Buy)

    Exercise: $47.60Exp: 2026-08-07Common Stock (228,600 underlying)
    228,600
  • Stock Options (Right to Buy)

    Exercise: $66.97Exp: 2027-08-05Common Stock (66,600 underlying)
    66,600
  • Stock Options (Right to Buy)

    Exercise: $66.97Exp: 2027-08-05Common Stock (299,768 underlying)
    299,768
  • Stock Options (Right to Buy)

    Exercise: $66.97Exp: 2027-08-05Common Stock (153,180 underlying)
    153,180
  • Stock Options (Right to Buy)

    Exercise: $120.45Exp: 2028-08-06Common Stock (125,260 underlying)
    125,260
  • Stock Options (Right to Buy)

    Exercise: $94.52Exp: 2029-08-15Common Stock (600,000 underlying)
    600,000
Footnotes (8)
  • [F1]Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024.
  • [F2]Fully exercisable.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F4]17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024.
  • [F5]Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
  • [F6]Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F7]Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
  • [F8]600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001534980

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:13 PM ET
Size
22.9 KB